La Marató de TV3 and Catalunya Ràdio in 2020, dedicated to COVID-19, will give 12.5 million euros to fund 36 excellence biomedical research projects to improve the quality and life expectancy of people affected by SARS-CoV-2.
The 2020 edition received 229 projects, assessed by ninety-five scientists from international fields, experts on this issue. The assessment criteria were quality, methodology and relevance of the proposals. The management of such assessment was carried out by the Agency for Health Quality and Assessment of Catalonia, from the Department of Health of the Catalan Government.
Like in previous editions, La Marató’s call will promote awarded UB research projects to fight COVID-19
Awarded projects in La Marató 2020 linked to the University of Barcelona
"Assessment of COVID-19 outbreak through wastewater epidemiology: typing, community screening and occupational risk"
SÃlvia Bofill Mas, Faculty of Biology (University of Barcelona); LluÃs Corominas Tabares, Water Research Institute Foundation (ICRA); Nùria Canela Canela, Eurecat Foundation and Technological Centre of Catalonia (Eurecat)
"Security and immunogenicity of the ARNm SARS-CoV-2 vaccine in solid organ transplant receptors: multicenter study"
Marta Bodro Marimont, August Pi i Sunyer Biomedical Research Institute Consortium, IDIBAPS and Hospital ClÃnic de Barcelona; Marta Crespo Barrio, Hospital del Mar Biomedical Research Instiute (IMIM); Sénia Mirabet Pérez, Hospital de la Santa Creu i Sant Pau Research Institute (IRHSCSP) Funding: 230,545.00 €
"Reduction of the psychosocial impact of the COVID-19 pandemic in nursing home staff"
Josep Maria Haro Abad, Institute for Research and Teaching Sant Joan de Déu Private Foundation; Ellen Marïet Sijbrandij, Free University of Amsterdam; José Luis Ayuso Mateos, Faculty of Medicine of the Autonomous University of Madrid Funding: 309,920.00 €
"Understanding the role of human genetic variation and mediated phenocopies by antibodies in susceptibility to severe COVID-19"
Conxi LÃ¡zaro GarcÃa, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology and IDIBELL; Xavier Corbella Virós, BellvitgeUniversity Hospital
Funding: 299,998.84 €
"Monitoring respiratory pattern of patients with severe COVID-19 pneumonia using a new non-invasive device"
Beatriz Giraldo Giraldo, Institute for Bionengineering of Catalonia (IBEC) Arantxa Mas Serra, Bellvitge Biomedical Research Institute (IDIBELL) and Integral Health Consortium (CSI)
Funding: 286,445.63 €
"Prediction of respiratory pronostic in patients with severe COVID-10 using metabolic signatures (CoRespirOmics)"
Santiago Marco ColÃ¡s, Institute for Bioengineering of Catalonia (IBEC); Joan Ramon Masclans Enviz, Hospital del Mar Biomedical Research Institute (IMIM)
Funding: 295,750.00 €
"Composition of microbiota as a risk predictor in cancer patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection"
VÃctor Raùl Moreno Aguado, Bellvitge Biomedical Research Instiute (IDIBELL) and Catalan Institute of Oncology (ICO); Paolo Nuciforo, Vall d’Hebron Institute on Oncology (VHIO)
Funding: 299,820.19 €
"Male reproductive function in COVID-19 patients"
Rafael Oliva Virgili, Clinic Foundation for Biomedical Research Foundation - Hospital ClÃnic de Barcelona (FCRB); Daniel Moreno Mendoza, Hospital de la Santa Creu i Sant Pau Research Institute and Puigvert Foundation (IRHSCSP); Melchor Carbonell Socias, Vall d’Hebron Research Institute (VHIR); Ignasi Roig Navarro, Autonomous University of Barcelona; Beatriz CandÃ¡s Estébanez, Hospital de Barcelona and Healthcare Facilities Cooperative Society (SCIAS)
Funding: 399,821.25 €
"Efficiency and neurologic adverse effects of the vaccine against COVID-19 in immunoexpressed multiple sclerosis patients"
Albert Saiz Hinarejos, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Hospital ClÃnic de Barcelona; ThaÃs Armangué Salvador, Hospital Sant Joan de Déu Foundation for Research and Teaching; Luis Antonio Querol Gutiérrez, Hospital de la Santa Creu i Sant Pau Research Institute (IRHSCSP)
Funding: 397,442.50 €
"Interaction between ACE2 and AXL systems to predict the severity and results of COVID-19"
José TomÃ¡s Ortiz Pérez, August Pi i Sunyer Biomedical Research Instiute (IDIBAPS) and Hospital ClÃnic de Barcelona; MarÃa José Soler Romeo, Vall d’Hebron Research Institute (VHIR); Albert Morales Muñoz, Biomedical Research Institute of Barcelona (IIBB-CSIC)
Funding: 399,315.53 ¤